|1.||Juronen, Erkki: 1 article (01/2013)|
|2.||Patarroyo, Manuel: 1 article (01/2013)|
|3.||Virtanen, Ismo: 1 article (01/2013)|
|4.||Omrani, Shahin: 1 article (01/2013)|
|5.||Wondimu, Zenebech: 1 article (01/2013)|
|6.||Javed, Fawad: 1 article (01/2013)|
|7.||Oikawa, Yuko: 1 article (01/2013)|
|8.||Ishikawa, Taichi: 1 article (01/2013)|
|9.||Ingerpuu, Sulev: 1 article (01/2013)|
01/01/2013 - "Of greatest interest, mAb 8G9, but not any other antibody, strongly inhibited α3β1/α6β1 integrin-mediated adhesion and migration of glioma, melanoma, and carcinoma cells on laminin-511 and, together with mAb 4C7, on laminin-521. "
05/01/1985 - "One epitope, identified by Mab 4C7, is expressed only on mucinous carcinoma, endometrioid carcinoma, and mesonephroid carcinoma, while the epitope, identified by Mab 3C2, appears only on serous and endometrioid carcinoma."
|3.||B-Cell Lymphoma (Lymphoma, B Cell)
12/01/1997 - "Therefore, we tested the utility of monoclonal antibody (MAb) 4C7 to detect CD5 on paraffin sections of 22 cases with low-grade B-cell lymphomas and 4 cases with high-grade B-cell lymphomas and compared the results with CD5 detection by analysis of fresh tissue with a fluorescent-activated cell sorting (FACS). "
|4.||Muscular Dystrophies (Muscular Dystrophy)
|5.||Melanoma (Melanoma, Malignant)